1. Introduction {#sec1}
===============

Primary sarcomas of the breast are rare tumors accounting for less than 1% of all breast neoplasms, just a handful of which are leiomyosarcoma. This tumor occurs usually in postmenopausal women, with most of the reported cases being between the age of fifty and eighty years \[[@B1]--[@B35]\]. Its occurrence in very young girls \[[@B8], [@B20]\] is extremely rare and may be clinically mistaken for fibroadenoma. In this paper, we present the clinical features of an adolescent girl with primary leiomyosarcoma of the breast, its pathological features, and an up-to-date review of literature on the topic.

2. Case Report {#sec2}
==============

2.1. Clinical Presentation and Examination {#sec2.1}
------------------------------------------

A 19-year-old adolescent girl presented with a rapidly increasing, painless mass in the left breast for 6-month duration. On clinical examination, the mass measured 8 cm in diameter, was well defined, lobulated, firm, and mobile with the overlying skin and nipple-areola being normal. No axillary lymph nodes were palpable. The patient did not have any family history of breast cancer or any other comorbidity. An ultrasound examination of the breast identified the mass to be well circumscribed, oval and was diagnosed as likely to be a fibroadenoma. Systemic physical, radiological, and ultrasound examination did not identify any suspicious mass in any other part of the body. The patient underwent an excision of the breast lump with the aim of diagnosis and relief of symptoms.

2.2. Pathological Findings {#sec2.2}
--------------------------

Grossly, the specimen composed of single, large, globular, and well-encapsulated mass measuring 7 cm in diameter (Figures [1(a)](#fig1){ref-type="fig"}, [1(b)](#fig1){ref-type="fig"}). The mass was pearly white in color on both the outer surface as well as the cut surface with areas of whorling. No areas of hemorrhage, cystic degeneration, or necrosis were noted grossly. However, focal areas of myxoid change were seen. Microscopically, (Figures [1(c)](#fig1){ref-type="fig"}, [1(d)](#fig1){ref-type="fig"}, and [1(e)](#fig1){ref-type="fig"}) the tumor was well-circumscribed, well-encapsulated, and composed of spindle cells arranged as intersecting long fascicles in a collagenous background. Individual tumor cells were moderately pleomorphic with round to oval nuclei, vesicular chromatin, and moderate amount of eosinophilic spindled cytoplasm. Binucleation and multinucleation were frequently noted, as was mitotic activity (20--25/10 high power field). Few myxoid areas were noted with interspersed thin-walled blood vessels and microscopic areas of necrosis. No epithelial component was noted in any part of the tumor. The mass was completely excised with a rim of normal breast tissue containing terminal duct lobular units surrounded by mild fibrosis.

Immunohistochemistry ([Figure 1(f)](#fig1){ref-type="fig"}) performed by the peroxidase technique showed the tumor cells to be strongly positive for smooth muscle actin and vimentin, while they were negative for pan-cytokeratin and desmin.

3. Discussion {#sec3}
=============

Breast sarcomas are rare tumors accounting for about 0.5--1.0% of all breast neoplasms. Of these, cystosarcoma phylloides is the most common neoplasm, while only a handful of cases have been reported in the literature to be primary leiomyosarcoma of breast \[[@B1]--[@B35]\]. A comparison of clinicopathological features of primary leiomyosarcoma of breast reported in the English literature till date is presented in [Table 1](#tab1){ref-type="table"}. In the largest series on breast sarcomas from the Mayo clinic, spread over a span of 90 years (1910--2000), Adem et al. \[[@B1]\] reported twenty five cases of primary breast sarcomas, of which only two were leiomyosarcoma. In the largest series on primary breast sarcomas from India, none of the 19 cases reported was a leiomyosarcoma \[[@B36]\]. Most of the patients reported till date of primary breast leiomyosarcoma have been postmenopausal, typically in the six-eighth decade. However, our patient is one of the two reported cases \[[@B8]\] of a young girl in her late teens to be diagnosed with a primary breast sarcoma. As with other sarcomas, prior chemotherapy for either a primary breast carcinoma or any other malignancy is a risk factor reported in the literature \[[@B6]\]. The exact cell of origin of this tumor is still debated with origin from smooth muscle of blood vessels, or that of the nipple areola complex and myofibroblasts undergoing myoid transformation being candidate histogenetic mechanisms \[[@B3], [@B25]\].

There is no clear consensus on the best treatment modality. However, the basic aim of treatment should be a complete excision with negative margins. Most cases reported have undergone mastectomy; however cases treated by lumpectomy have been reported albeit with a marginally higher incidence of recurrence and metastases \[[@B2], [@B4]\]. Prognosis is determined primarily by the adequacy of surgical resection. Although, there is no definite consensus on the use of adjuvant chemotherapy or radiotherapy, most patients reported till date have done well without any chemotherapy or radiotherapy, at least in the initial few years (see [Table 1](#tab1){ref-type="table"}). The benefit of chemotherapy or radiation in preventing a recurrence many years later needs to be balanced by the risk of second malignancy. Most patients undergo mastectomy or at least wide local excision, as in our case. There is probably no role for axillary dissection, as there is no reason to believe that leiomyosarcomas follow a lymphatic route of dissemination. Even in cases which had palpable axillary nodes, axillary node dissection did not show any evidence of metastasis ([Table 1](#tab1){ref-type="table"}).

In conclusion, leiomyosarcoma of the breast is a rare entity with patients typically being in the 5th−7th decade; however it can rarely occur in younger patients as in our case. Morphologically it can be suspected by the typical histological features of circumscription, high cellularity and being composed of fusiform spindle cells having blunt end nuclei. Confirmation by an immunohistochemical profile of smooth muscle actin, vimentin, and desmin positivity is helpful; however, cases negative for some of these immunostains especially desmin have been reported. Demonstration of myofilaments on electron microscopy can help in those cases.
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![Gross photographs showing the external aspect (a) and cut surface (b) of the specimen showing a well-circumscribed and encapsulated mass with a thin rim of breast parenchyma surrounding it. The tumor is homogenous, whitish with areas of myxoid change. (c, d, e) Progressive increasing magnification of histology (40x, 100x and 400x) showing the well-encapsulated mass composed of intersecting fascicles of spindle cells with frequent mitoses. (f) Peroxidase-based immunohistochemistry for smooth muscle actin (SMA) showing diffuse, strong cytoplasmic positivity.](CRIM.PATHOLOGY2012-491984.001){#fig1}

###### 

Comparison of clinicopathological variables of all the cases of primary leiomyosarcoma of breast reported in the English literature.

  Author                             Year   Age/Sex   size (cm)                      Mitosis (/10hpf)   Treatment                    Ct/Rt   Final followup
  ---------------------------------- ------ --------- ------------------------------ ------------------ ---------------------------- ------- -----------------------------------------------------------
  Haagensen \[[@B35]\]               1971   77/F      8                              very frequent      SM                           ---     Alive, 14 years
  Pardo Mindan et al. \[[@B25]\]     1974   49/F      7                              16                 SM                           ---     Alive, 6 months
  Barnes and Pietruszka \[[@B37]\]   1977   55/F      3                              10                 SM                           ---     Died 4 years 4 months later with basilar arterythrombosis
  Hernandez \[[@B13]\]               1978   53/M      4                              15                 MRM                          ---     Alive, 1 year 2 months
  Chen et al. \[[@B4]\]              1981   59/F      5.6                            3                  SM                           ---     Alive, 15 years
  Callery et al. \[[@B38]\]          1984   56/F      2                                                 SM                           ---     Alive, 39 months
  Callery et al. \[[@B38]\]          1984   54/F      3                                                 SM                           ---     Alive, 53 months
  Yatsuka et al. \[[@B39]\]          1984   56/F      1.5                            21                 RM                           ---     Alive, 4 years 7 months
  Gobardhan \[[@B9]\]                1984   50/F      9                              5                  MRM                          ---     Alive, 2 years
  Nielsen \[[@B24]\]                 1984   24/F      1.5 (1962) 1 (1965) 2 (1966)   2, 8, 14           WLE (1962), SM (1965)        ---     Died 20 years later
  Yamashina \[[@B33]\]               1987   62/F      2.5                            11                 SM                           ---     Alive, 2 years 2 months
  Arista-Nasr et al. \[[@B2]\]       1989   50/F      4.5 (1980), 2.3 (1986)         4                  WLE                          ---     Alive, 6 years 4 months
  Parham et al. \[[@B26]\]           1992   52/F      3                              29                 SM                           ---     Alive, 6 months
  Lonsdale and Widdison \[[@B21]\]   1992   60/F      2, 4 (18 mths later)           10                 SM                           ---     Alive, 3 months,
  Waterworth et al. \[[@B34]\]       1992   58/F      4                              10                 WLE + AC                     ---     Alive, 1 year
  Wei et al. \[[@B16]\]              1993   36/F      4                                                 MRM                          ---     Died 14 months later
  Boscaino et al. \[[@B40]\]         1994   56/F      2.5/4                          2                  WLE (1981)/RM (1984)         ---     Alive, 9 years
  Boscaino et al. \[[@B40]\]         1994   45/F      1.9 (1985)/2.2 (1989)          2                  E (1985)/WLE(1989)           ---     Alive, 40 months, post wide local excision
  Levy et al. \[[@B19]\]             1995   35/F      4                              2                  SM                           ---     Alive, 6 months
  Falconieri et al. \[[@B7]\]        1997   83/F      6                              20                 RM                           ---     Alive, 10 months
  Falconieri et al. \[[@B7]\]        1997   86/F      8                              11                 SM                           ---     Alive, 8 months
  Ugras et al. \[[@B31]\]            1997   47/F      2                              3                  SM                           ---     Alive, 1 year 6 months
  González-Palacios \[[@B10]\]       1998   62/F      3                              10                 SM                           ---     Alive, 17 years
  Gupta et al. \[[@B12]\]            2000   80/F      6.5                            5--8               SM + AC                      ---     Alive, 2 years
  Székely et al. \[[@B30]\]          2001   73/F      4.8                            20--22             SM                           ---     Alive, 1 year
  Kusama et al. \[[@B17]\]           2002   55/F      0.5/-                          few                WLE (1996, 1997)/SM (1998)   ---     Alive, 4 years 8 months
  Shinto et al. \[[@B28]\]           2002   59/F      12                             19                 SM                           Ct      Alive, 8 months
  Wei et al. \[[@B16]\]              2003   52/F      4                              22                 WLE                          ---     Alive, 3 months
  Markaki et al. \[[@B22]\]          2003   42/F      14                             50                 MRM                          Ct      Alive, 3 years
  Markaki et al. \[[@B22]\]          2003   65/F      5,2                            10                 E                            ---     Alive, 18 months
  Liang et al. \[[@B20]\]            2003   25/F      4                              5                  E                            ---     Alive, 32 months
  Adem et al. \[[@B1]\]              2004   67/F      2                                                 E                            ---     Died 7 months later
  Adem et al. \[[@B1]\]              2004   55/F      4                                                 SM                           ---     Died 77 months later
  Jayaram et al. \[[@B15]\]          2004   55/F      12                                                MRM                          ---     Local recurrence
  Lee et al. \[[@B18]\]              2004   44/F      3                              6--12              SM                           ---     Alive, 13 months
  Lee et al. \[[@B18]\]              2004   52/F      4.5                            6--12              SM                           ---     Alive, 17 months
  Stafyla et al. \[[@B29]\]          2004   53/F      23                                                MRM                          Rt      Alive, 2 years
  Munitiz et al. \[[@B23]\]          2004   58/F      4                              14                 MRM                          ---     Alive, 1 year
  Gupta \[[@B11]\]                   2006   37/F      8                              15                 WLE                          ---     Alive, 36 months
  Vu et al. \[[@B32]\]               2006   -/F       23                                                SM                           ---     Alive, 10 months
  De la Pena and Wapnir \[[@B6]\]    2008   50/F      3.2                                               SM                           ---     Alive, 11 months
  Wong et al. \[[@B41]\]             2008   52/F      1.5                            7                  SM                           ---     Alive, 4 days
  Cobanoglu et al. \[[@B5]\]         2009   64/F      3.5                            12                 MRM                          ---     Alive, 22 months
  Fujita et al. \[[@B8]\]            2010   18/F      7.2                            10                 SM                           Rt      Alive, 5 years
  Present Case                       2011   19/F      7                              20--25             WLE                          ---     Alive, 3years

Ct: Chemotherapy, Rt: Radiotherapy, SM: Simple Mastectomy, RM: Radical Mastectomy, MRM: Modified Radical Mastectomy.
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